GLA and Fabry disease: The diagnosis of FD is established by: (1) reduced levels of α-Gal A activity in blood leukocytes, whole blood (dried blood spot), or in tissues; (2) increased plasma globotriaosylsphingosine (lyso-Gb3) concentration, and (3) disease-causing GLA gene mutation [12,13,14].